Placebo - Cap: Clinical Trials

9 trials of Placebo - Cap, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 terminated. 9 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Completed 6, Terminated 3
Phase 11Completed 1
Phase 31Completed 1

Follow Placebo - Cap: new trials by email Literature Review of Placebo - Cap trials Research Report on Placebo - Cap

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cabergoline for the Treatment of Chronic Pain Due to Endometriosis
Cabergoline 0.5 MG, Placebo - Cap - Endometriosis
Phase 2CompletedBoston Children's Hospital1292019-12-022026-01-28
ENAC Blockade and Arterial Stiffness
Placebo - Cap, Amiloride Pill - Overweight and Obesity, Insulin Resistance
Phase 2 / Phase 3CompletedUniversity of Missouri-Columbia1372019-07-152025-12-30
Fexofenadine Use in Gastroesophageal Reflux Symptoms
Fexofenadine, Placebo - Cap - Gastroesophageal Reflux
Phase 2TerminatedStanford University112018-02-072021-02-17
INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers
Mifepristone, Placebo - Cap - Alcohol Use Disorder
Phase 1 / Phase 2CompletedJohns Hopkins University652017-09-262025-05-30
OPTIMA-TBI Pilot Study
Omega-3 Polyunsaturated Fatty Acids (Fish Oil 1000 mg (contains 500 mg DHA & 100 mg EPA)) or placebo capsules., Placebo - Cap - Mild Traumatic Brain Injury
Phase 2TerminatedUniversity of Michigan442017-09-122023-05-23
A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia
SEP-363856, Placebo - Cap - Schizophrenia
Phase 2CompletedOtsuka Pharmaceutical Development & Commercialization, Inc.2452016-12-052024-07-05
Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer
escitalopram, Moclobemide, Placebo - Cap - Addiction
Phase 2TerminatedChina Medical University Hospital902016-01-142019-07-24
NMDA Modulation in Major Depressive Disorder in Late- Life
NMDA, Sertraline, Placebo - Cap - Depressive Disorder, Major
Phase 2CompletedChang Gung Memorial Hospital1362016-01-012020-12-01
Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function
Anastrozole 1mg, Clomiphene Citrate 25mg, Placebo - Cap - Hypogonadism, Male
Phase 2CompletedAlbany Medical College242015-04-022019-11-18

Conditions studied

Alcoholism (1)  ·  Behavior, Addictive (1)  ·  Brain Concussion (1)  ·  Depressive Disorder, Major (1)  ·  Endometriosis (1)  ·  Eunuchism (1)  ·  Gastroesophageal Reflux (1)  ·  Insulin Resistance (1)  ·  Obesity (1)  ·  Overweight (1)  ·  Schizophrenia (1)

Sponsors

Albany Medical College (1)  ·  Boston Children's Hospital (1)  ·  Chang Gung Memorial Hospital (1)  ·  China Medical University Hospital (1)  ·  Johns Hopkins University (1)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (1)  ·  Stanford University (1)  ·  University of Michigan (1)  ·  University of Missouri-Columbia (1)

Countries

United States (6)  ·  Hungary (1)  ·  Romania (1)  ·  Russia (1)  ·  Taiwan (1)  ·  Ukraine (1)

Top investigators

Camila Manrique Acevedo, MD (1)  ·  Frederick Korley, M.D., Ph.D. (1)  ·  Ko Ying-Chin, PHD (1)  ·  Mary E McCaul, PhD (1)  ·  Robert C Welliver, MD (1)

Results publications

PMID 32294346, PMID 35023557, PMID 36369028

NIH funding

2016 (1), U01AA020890 (1)